Carcinoma of the thyroid gland is an uncommon cancer, but one of the most frequent malignancies of the endocrine system. Most thyroid cancers are derived from the follicular cell. Follicular carcinoma is considered more malignant than papillary thyroid carcinoma (PTC), and anaplastic thyroid cancer (ATC) is one of the most lethal human cancers.
INTRODUCTION
The thyroid gland is composed of two distinct hormone-producing cell types: follicular cells and parafollicular C cells. Follicular cells, present in the monolayer epithelium, are responsible for iodine uptake and thyroid hormone synthesis. C cells are intrafollicular or parafollicular cells, responsible for the production of the calcium-regulating hormone calcitonin. The majority of thyroid tumors (more than 95%) are derived from follicular cells while a minority (3%), called medullary thyroid carcinomas, are C-cell derived carcinomas (Carcangiu et al. 1984; LiVolsi & Asa 1994; DeLellis et al. 2004; Kondo et al. 2006) . (Carcangiu et al. 1984; LiVolsi & Asa 1994; DeLellis et al. 2004; Kondo et al. 2006) . WDTCs include papillary (PTC) and follicular (FTC) types.
PTCs are characterized by classical papillary architecture and cells with typical nuclear alterations (ground-glass nuclei) (DeLellis et al. 2004 ).
Very often PTCs are multifocal and tend to metastasize to the regional lymph nodes. FTC is a quite uncommon tumor, accounting for about 10% of all thyroid carcinomas. It may be of conventional or oncocytic (Hurthle cell) type (DeLellis et al. 2004) . FTC is well-differentiated, ATCs are very rare tumors estimated to comprise about 2-5% of thyroid malignancies. ATCs are highly undifferentiated, extremely aggressive and insensitive to conventional radiotherapy and chemotherapy (Ain 1999; Yau et al. 2008) . ATCs may derive from the progression of preexisting PTCs and FTCs. Such hypothesis is validated by the presence, in some patients, of undifferentiated (anaplastic) areas that co-exist with more differentiated areas of papillary or follicular type (Ain 1999) . As far as PDTCs are concerned, their morphology and behavior is intermediate between well-differentiated and undifferentiated thyroid carcinomas (Carcangiu et al. 1984; DeLellis et al. 2004 ).
Radiation exposure is the major risk factor for PTC. Indeed, PTC incidence was verified among the atomic bomb survivors of Hiroshima and Nagasaki (Williams 2002 ). In the 1950s, patients treated with irradiation in the head and neck region for the cure of thymic hyperplasia or mycotic infections developed higher susceptibility to PTC.
Furthermore, after the nuclear reaction accident of Chernobyl in April 1986, children, mostly in Belarus and Ukraine, exhibited an increased PTC incidence (up to 100 times). It was also found that Post-Chernobyl PTCs, often presenting a particular type of histology with dense cell structure (solid PTC variant), were more aggressive than those found in regions not exposed to radiations (Williams 2002 ).
Endemic goiter due to the lack of iodine represents one of the major risk In PTC, BRAF mutation and RET/PTC rearrangements are mutually exclusive and cannot be found simultaneously in the same patients, yet they are not completely equivalent, since it has been shown that PTCs positive for BRAF are more aggressive than those positive to RET/PTC (Kimura et al. 2003; Soares et al. 2003) .
It has recently been demonstrated that some types of PTC developed after FTCs and with lower prevalence also in oncocytic carcinomas (French et al. 2003; Nikiforova et al. 2003; Dwight et al. 2003) .
PDTC and ATC can originate from WDTC and, in particular, from PTC.
Therefore, mutations that occur in the early stages of WDTC are also observed in PDTC and ATC: in PDTC are observed RET rearrangements (13%) as well as RAS (46-55%) and BRAF (12-17%) mutations, while in ATC only mutations of RAS (6-52%) and BRAF (25-29%) are reported (Santoro et al. 2002; Hou et al. 2007; Santarpia et al. 2008; GarciaRostan et al. 2005) (Table 1) .
Alterations of PIK3CA and PTEN (effectors of phosphoinositide 3- MicroRNAs ( 
MiRNA expression profile in Papillary Thyroid Carcinomas
Most studies have focused on the analysis of miRNA expression profile of PTCs by "miRNACHIP" microarray revealing the upregulation of a set of seven miRNAs in PTCs compared with the normal thyroid, -221, -222, -146, -21, -155, -181a and -181b (Table 2) . et al. 2008) . In another study the expression of a set of seven miRNAs (miR-187, -221, -222, -224, -146b, -155 and -197) was analyzed in FNA specimens of thyroid carcinomas and of hyperplastic nodules (Nikiforova et al. 2008) . The evaluation of these miRNAs was very useful in differentiating thyroid cancer from hyperplastic nodules. In fact, the supervised prediction analysis by linear discriminant analysis failed to distinguish only one of 41 malignant tumors and hyperplastic nodules (Nikiforova et al. 2008) . These results indicated the evaluation of these miRNAs as a potential application for the diagnosis of human thyroid neoplasias.
Role of the miR-221/222 cluster in thyroid carcinogenesis
MiR-221 and -222 are the most consistently upregulated miRNAs in PTC. They are very similar in sequence, clustered on chromosome X and are likely transcribed as polycistrons (Ciafre' et al. 2005) . Functional studies were performed to understand their role in thyroid carcinogenesis. (Serrano et al. 1993; Hannon et al. 1994; Guan et al. 1994; Hirai et al. 1995) . These proteins contrast the activities of CDKs which are involved in the regulation of the mitogen-dependent progression through gap phase 1 (G1 phase) and initiation of DNA synthesis (S phase) during the mammalian cell division cycle (Kaldis 2007). Reduced p27 Kip1 protein levels were found in a high number of human thyroid malignancies in the absence of significant changes in p27 mRNA levels (Baldassarre et al. 1999) . When transfected 
2009).
In conclusion, the overexpression of miR-221 and -222 targets critical genes making their overexpression a crucial factor in the process of thyroid oncogenesis.
MiR-146 in thyroid cancer

MiR-146 represents one of the most upregulated miRNAs in PTCs. It identifies two different miRNAs that differ only for two nucleotides:
miR-146a (on chromosome 5q33) and -146b (on chromosome 10q24). Since miR-146a and -146b show high sequence homology, they share many predicted targets, but each of them has specific targets. MiR-146
suppresses nuclear factor kappa-B (NF-kB) activity that regulates its expression (Taganov et al. 2006; Bhaumik et al. 2008) . Moreover, the breast cancer metastasis suppressor 1 (BRMS1) up-regulates miR-146a
and -146b, which suppress breast cancer metastasis since they are able to inhibit migration and invasion likely reducing the signaling through the et al. 2009 ). This appears to be a rather interesting novel principle of local feedback regulatory circuits.
NF-kB pathway (Hurst
Because the role of NF-kB in thyroid carcinogenesis has been already clearly well established (Visconti et al. 1997; Pacifico et al. 2004; McCall et al. 2007) , we can assume that the miR-146 overexpression might contribute to the development of PTCs.
Other targets of miR-146 are: interleukin 1 receptor-associated kinase 1 (IRAK1) (Taganov et al. 2006; Bhaumik et al. 2008) , TNF receptorassociated factor 6 (TRAF6) (Taganov et al. 2006; Bhaumik et al. 2008) , interleukin 8 (IL-8) (Bhaumik et al. 2008) , interleukin 6 (IL-6) (Bhaumik et al. 2008 ), C-X-C chemokine receptor type 4 (CXCR4) (Labbaye et al. 2008) , matrix metalloproteinase 9 (MMP9) (Bhaumik et al. 2008) , and 
MiRNAs downregulated in Papillary Thyroid Carcinomas
Our group, by analyzing more PTC samples, has recently found other miRNAs deregulated in PTCs (Table 2) miR-1, -191, -486, and -451 . These miRNAs showed lower expression levels in most of the PTCs analyzed compared to normal thyroid tissue. We have found that miR-1 is able to target CXCR4 (V Leone, submitted for publication). This protein, also called fusin, is an alpha-chemokine receptor specific for stromal cell-derived factor-1 (SDF-1 also called CXCL12), a molecule endowed with potent chemotactic activity for lymphocytes (Bleul et al. 1996) . CXCR4 is frequently overexpressed in PTCs and plays a major role in the mechanism of lymph node metastasis from primary tumor -187, -224, -155, -222, and -221, and in oncocytic variants were miR-187, -221, -339, -183, -222, and -197, whereas the most highly upregulated miRNAs in conventional FTAs
were miR-339, -224, -205, -210, -190, -328 and -342, and in oncocytic variants were miR-31, -339, -183, -221, -224 and -203 (Nikiforova et al. 2008) . Interestingly, the upregulation of these miRNAs was not observed in hyperplastic nodules. In another study Weber et al. identified four miRNAs differentially expressed between (Weber et al. 2006) . Moreover, in vitro functional analyses showed that the overexpression of miR-197 and -346 induced marked cell proliferation in HEK293T cells, while their inhibition caused growth arrest in human thyroid carcinoma follicular cells (FTC133) (Weber et al. 2006) . They also confirmed the regulation of three target genes by miR-197 (ACVR1 and TSPAN3) and -346 (EFEMP2). EFEMP2
seems to have tumor suppression functions (Argraves et al. 2003; Gallagher et al. 2001) , whereas ACVR1 is involved in the control of cell growth (Schulte et al. 2001) . TSPAN3 belongs to the tetraspan superfamily, whose members have been shown to be inversely correlated with the acquisition of metastatic potential in melanoma (Boucheix et al. 2001; Schulte et al. 2000) .
MiRNA expression Anaplastic Thyroid Carcinomas
As far as ATCs are concerned, a significant downregulation of miR-30d, -125b, -26a and -30a-5p has been described (Table 2) A recent study revealed an upregulation of several miRNAs in ATC (Table 2) . Interestingly, these miRNAs were found to be overexpressed Another study (Mitomo et al. 2008) revealed that miR-21, -146b, -221 and -222 were overexpressed in ATCs ( miR-17-5p, -17-3p, -18a, -19a, -20a, -19b and -92-1) , as well as miR-106a and -106b were ovexpressed in ATC cell lines (Takakura et al. 2008). MiR-17-3p and -17-5p resulted overexpressed also in human ATC samples compared to normal tissue. The inhibition of -17-3p, -17-5p and -19a resulted in a reduced cell growth, thus suggesting an oncogenic potential of these miRNAs. In this study, retinoblastoma protein (RB1) and PTEN, predicted to be putative targets in previously studies (Griffiths-Jones et al. 2006) , are now confirmed to be targets of miR- 17-5p and -19a (Takakura et al. 2008) . 
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